Pack de 10 viales7 en stockAhorra 25%Tesamorelin 20 mg
Análogo estabilizado de GHRH
Tesamorelin GHRH analogue research peptide, Australian-shipped. Lab-verified ≥99% purity.
Solo para uso en investigación. Este compuesto se vende estrictamente para investigación in vitro y fines de laboratorio, y no está destinado al consumo humano ni a uso terapéutico. Al comprar, usted confirma que es un investigador calificado y acepta nuestro aviso legal completo.
Solo quedan 7 packs
Análogo estabilizado de la hormona liberadora de hormona de crecimiento, estudiado por sus efectos sobre el tejido adiposo visceral y la actividad del eje IGF-1 en modelos de investigación.
Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) — modified to extend its half-life relative to native GHRH. It is one of the most studied GHRH-analogue research peptides and the only one of its class to have undergone regulatory approval in any jurisdiction (for HIV-associated lipodystrophy, in the US, under the brand name Egrifta). Quantum Labs supplies Tesamorelin as a lyophilised powder for Australian research applications.
Research on Tesamorelin has covered models of growth-hormone secretion, body composition, lipid metabolism, and IGF-1 dynamics. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mecanismo
Estudiado por la unión selectiva al receptor de GHRH con vida media prolongada. Investigación asociada con la reducción de marcadores de grasa visceral y con la elevación de IGF-1 en poblaciones de estudio.
Verificado por HPLC frente a una especificación de pureza ≥99 %. Analizado de forma independiente por laboratorios acreditados de terceros.
Tesamorelin — preguntas frecuentes
What is Tesamorelin?
Tesamorelin is a stabilised synthetic analogue of growth-hormone-releasing hormone (GHRH). It is studied in growth-hormone research and pre-clinical models of metabolic regulation and body composition.
Is Tesamorelin legal in Australia?
Tesamorelin is not approved as a therapeutic in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Tesamorelin for research use only.
What is the difference between Tesamorelin and CJC-1295?
Both are GHRH-analogue research peptides. CJC-1295 has a longer half-life and a stronger ability to extend the duration of GH pulses; Tesamorelin's modifications produce a shorter-acting but well-characterised GHRH-mimicking profile. They are studied as parallel research tools for different aspects of GHRH-pathway signalling.
What is the typical Tesamorelin research dosage?
Published clinical research (in the US, for the approved indication) has used 2 mg daily subcutaneous Tesamorelin. Research-protocol dosing varies by model. Human therapeutic dosing is not established in Australia.
Guías relacionadas con Tesamorelin
Los investigadores también exploran
DestacadoPack de 10 vialesAhorra 25%Retatrutide
Polvo liofilizado10 mg · 8 strengths
Péptido de investigación triagonista de GLP-1 / GIP / glucagón
En 1 combinación
Pack de 10 vialesAhorra 22%MOTS-c
Polvo liofilizado10 mg · 2 strengths
Péptido metabólico de origen mitocondrial
En 2 combinaciones
Pack de 10 vialesAhorra 17%5-Amino-1MQ
Polvo liofilizado50 mg · 3 strengths
Compuesto de investigación inhibidor de NNMT